The US Food and Drug Administration (FDA) has warned an oncology drug company for repeatedly overstating the efficacy of its drug in advertisements while failing to adequately disclose the associated ...

The FDA this month issued a warning letter to ImmunityBio regarding promotional statements about cancer drug Anktiva that the ...

Last fall, FDA Commissioner Dr. Marty Makary declared war on drug commercials. He wrote a viewpoint published in JAMA (Sept.

A new enforcement action from FDA signals that executive podcast appearances can be regulated like traditional ads when ...

Wegovy pill by Novo Nordisk is now under scrutiny after the US Food and Drug Administration (FDA) raised concerns over a television advertisement. FDA said that the commercial includes "false and ...

The Food and Drug Administration has warned Novo Nordisk that a television advertisement promoting its newly launched Wegovy pill for obesity contains "false or misleading" claims, saying the spot ...

Bristol Myers Squibb and its subsidiary Karuna Therapeutics received the latest Untitled Letter from the Food and Drug Administration earlier this week. In a letter issued on December 15 to Nicole Van ...

As the FDA steadily churns out a stream of untitled letters chastising pharmaceutical advertisers’ direct-to-consumer materials, a commercial for Bristol Myers Squibb’s Cobenfy is taking its turn in ...

The Food and Drug Administration said Novo Nordisk's TV advertisement for its newly launched Wegovy pill for obesity included "false or misleading" claims about the medicine's abilities and benefits ...